South Africa’s Medtech Industry Ready For The Big Step Forward
Executive Summary
South Africa’s medtech industry awaits only dedicated regulation and, later, HTA, for the sector to flourish and make the $1 billion+ market the English-speaking medtech gateway to Africa.
You may also be interested in...
Medtechs Must Address South Africa Market With Serious Intent And Sensitivity
South Africa is like no other country, having emerged through difficult decades of social inequality to now be embracing, among other things, modern health-care delivery via new regulatory structures, a national development plan and a National Health Insurance program (NHI). It is a potentially lucrative opportunity, but medtech players need to be wise to particular localization needs when embracing the South African market.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.